Nectar Lifescience Ltd Annually Results

Gross Sales

1,908.4

1,925.83

1,746.56

1,925.52

1,763.74

Excise Duty

238.42

241.75

222.89

256.69

220.44

Net Sales

1,669.97

1,684.09

1,523.67

1,668.83

1,543.3

Other Operating Income

3.1

1.55

0.94

0.03

1.07

Other Income

1.89

13.03

42.24

11.29

2.72

Total Income

1,674.97

1,698.66

1,566.85

1,680.15

1,547.09

Total Expenditure

1,699.53

1,532.53

1,470.66

1,510.29

1,459.57

PBIDT

-24.57

166.13

96.19

169.86

87.52

Interest

74.58

87.14

79.49

78.81

112.03

PBDT

-99.14

78.99

16.7

91.05

-24.51

Depreciation

62.39

60.72

59.12

56.97

60.25

Minority Interest Before NP

0

0

0

0

0

Tax

0

0

0

0

8.59

Deferred Tax

-47.85

13.27

-18.24

9.03

-20.09

Reported Profit After Tax

-113.68

4.99

-24.18

25.05

-73.26

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-113.68

4.99

-24.18

25.05

-73.26

Extra-ordinary Items

0

0

0

0

-22.75

Adjusted Profit After Extra-ordinary item

-113.68

4.99

-24.18

25.05

-50.51

EPS (Unit Curr.)

-5.07

0.22

-1.08

1.15

-3.27

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

22.43

22.43

22.43

22.43

22.43

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-1.47

9.86

6.31

10.17

5.67

PBDTM(%)

-5.93

4.69

1.09

5.45

-1.58

PATM(%)

-6.8

0.29

-1.58

1.5

-4.74